QQQ   312.72 (+1.82%)
AAPL   160.77 (+1.98%)
MSFT   280.51 (+1.92%)
META   205.35 (+2.33%)
GOOGL   101.39 (+0.36%)
AMZN   100.25 (+3.10%)
TSLA   193.88 (+2.48%)
NVDA   269.84 (+2.17%)
NIO   9.83 (+6.85%)
BABA   99.92 (+1.54%)
AMD   96.09 (+1.62%)
T   19.00 (+1.50%)
F   12.05 (+3.88%)
MU   63.54 (+7.19%)
CGC   1.81 (+0.00%)
GE   94.06 (+0.99%)
DIS   96.87 (+2.16%)
AMC   5.00 (-2.91%)
PFE   40.25 (+0.65%)
PYPL   74.18 (+2.04%)
NFLX   332.03 (+2.63%)
QQQ   312.72 (+1.82%)
AAPL   160.77 (+1.98%)
MSFT   280.51 (+1.92%)
META   205.35 (+2.33%)
GOOGL   101.39 (+0.36%)
AMZN   100.25 (+3.10%)
TSLA   193.88 (+2.48%)
NVDA   269.84 (+2.17%)
NIO   9.83 (+6.85%)
BABA   99.92 (+1.54%)
AMD   96.09 (+1.62%)
T   19.00 (+1.50%)
F   12.05 (+3.88%)
MU   63.54 (+7.19%)
CGC   1.81 (+0.00%)
GE   94.06 (+0.99%)
DIS   96.87 (+2.16%)
AMC   5.00 (-2.91%)
PFE   40.25 (+0.65%)
PYPL   74.18 (+2.04%)
NFLX   332.03 (+2.63%)
QQQ   312.72 (+1.82%)
AAPL   160.77 (+1.98%)
MSFT   280.51 (+1.92%)
META   205.35 (+2.33%)
GOOGL   101.39 (+0.36%)
AMZN   100.25 (+3.10%)
TSLA   193.88 (+2.48%)
NVDA   269.84 (+2.17%)
NIO   9.83 (+6.85%)
BABA   99.92 (+1.54%)
AMD   96.09 (+1.62%)
T   19.00 (+1.50%)
F   12.05 (+3.88%)
MU   63.54 (+7.19%)
CGC   1.81 (+0.00%)
GE   94.06 (+0.99%)
DIS   96.87 (+2.16%)
AMC   5.00 (-2.91%)
PFE   40.25 (+0.65%)
PYPL   74.18 (+2.04%)
NFLX   332.03 (+2.63%)
QQQ   312.72 (+1.82%)
AAPL   160.77 (+1.98%)
MSFT   280.51 (+1.92%)
META   205.35 (+2.33%)
GOOGL   101.39 (+0.36%)
AMZN   100.25 (+3.10%)
TSLA   193.88 (+2.48%)
NVDA   269.84 (+2.17%)
NIO   9.83 (+6.85%)
BABA   99.92 (+1.54%)
AMD   96.09 (+1.62%)
T   19.00 (+1.50%)
F   12.05 (+3.88%)
MU   63.54 (+7.19%)
CGC   1.81 (+0.00%)
GE   94.06 (+0.99%)
DIS   96.87 (+2.16%)
AMC   5.00 (-2.91%)
PFE   40.25 (+0.65%)
PYPL   74.18 (+2.04%)
NFLX   332.03 (+2.63%)
NASDAQ:CPRX

Catalyst Pharmaceuticals - CPRX Earnings Date, Estimates & Call Transcripts

$16.72
+0.35 (+2.14%)
(As of 03/29/2023 12:00 AM ET)
Add
Compare
Today's Range
$16.45
$16.86
50-Day Range
$14.34
$20.80
52-Week Range
$6.15
$22.11
Volume
1.36 million shs
Average Volume
2.34 million shs
Market Capitalization
$1.77 billion
P/E Ratio
22.59
Dividend Yield
N/A
Price Target
$21.50
Skip Charts & View Estimated and Actual Earnings Data

CPRX Earnings Estimates and Actuals by Quarter

The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.

CPRX Estimated and Actual Revenue by Quarter

The chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter.

Catalyst Pharmaceuticals Analyst Forecasts

QuarterNumber of EstimatesLow EstimateHigh EstimateAverage EstimateCompany Guidance
Q1 20232$0.23$0.34$0.29 
Q2 20232$0.24$0.36$0.30 
Q3 20232$0.25$0.37$0.31 
Q4 20232$0.24$0.43$0.34 
FY 20238$0.96$1.50 $1.23

CPRX Earnings Date and Information

Catalyst Pharmaceuticals has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Tuesday, May 9th, 2023 based off prior year's report dates.

Catalyst Pharmaceuticals Earnings History by Quarter

DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueCall Transcript
5/9/2023
(Estimated)
        
11/9/2022Q3 2022$0.19$0.20+$0.01$0.20$53.80 million$57.24 million
8/9/2022Q2 2022$0.17$0.20+$0.03$0.20$49.29 million$53.11 million
5/10/2022Q1 2022$0.14$0.12($0.02)$0.12$43.17 million$43.09 million    
3/16/2022Q4 2021$0.12$0.09($0.03)$0.09$38.17 million$38.31 million    
11/9/20219/30/2021$0.10$0.10$0.10$34.47 million$35.95 million    
8/8/20216/30/2021$0.10$0.11+$0.01$0.17$31.25 million$36.37 million    
5/9/20213/31/2021$0.09$0.07($0.02)$0.11$32.14 million$30.21 million  
3/16/202112/31/2020$0.09$0.11+$0.02$0.11$30.06 million$31.02 million  
11/16/20209/30/2020$0.10$0.11+$0.01($0.19)$31.22 million$29.32 million  
8/10/20206/30/2020$0.08$0.09+$0.01$0.09$28.97 million$29.61 million  
5/11/20203/31/2020$0.09$0.10+$0.01$0.10$31.68 million$29.14 million  
3/16/202012/31/2019$0.10$0.08($0.02)$0.07$30.00 million$30.12 million  
11/12/2019Q3 2019$0.11$0.13+$0.02$0.13$33.19 million$30.90 million  
8/7/2019Q2 2019$0.03$0.10+$0.07$0.10$17.99 million$28.84 million  
5/13/20193/31/2019($0.13)($0.01)+$0.12($0.01)$2.40 million$12.45 million
3/18/201912/31/2018($0.12)($0.14)($0.02)($0.14)$0.50 million  
11/8/20189/30/2018($0.08)($0.08)($0.08)
8/10/2018Q2 2018($0.08)($0.0580)+$0.0220($0.06)
5/9/2018Q1 2018($0.06)($0.06)($0.06)
3/14/2018Q4 2017($0.06)($0.06)($0.06)  
11/8/2017Q3 2017($0.06)($0.05)+$0.01($0.05)
8/9/2017Q2 2017($0.06)($0.0460)+$0.0140($0.05)  
5/10/2017Q1 2017($0.06)($0.06)($0.06)
3/15/2017Q4 2016($0.07)($0.05)+$0.02($0.05)
11/9/2016Q316($0.06)($0.05)+$0.01($0.05)  
8/9/2016Q216($0.08)($0.06)+$0.02($0.06)
5/10/2016Q116($0.07)($0.07)($0.07)
3/15/2016Q415($0.07)($0.07)($0.07)
11/9/2015Q3 2015($0.07)($0.06)+$0.01($0.07)
8/10/2015Q215($0.08)($0.06)+$0.02($0.06)  
5/11/2015Q115($0.08)($0.06)+$0.02($0.05)
3/16/2015Q414($0.07)($0.06)+$0.01($0.07)
11/14/2014Q314($0.06)($0.06)($0.05)  
8/14/2014Q214($0.08)($0.05)+$0.03($0.05)
5/16/2014Q1 2014($0.08)($0.06)+$0.02($0.05)
3/19/2014Q4 2013($0.07)($0.05)+$0.02($0.07)
11/14/2013Q3 2013($0.07)($0.07)($0.01)
8/15/2013Q2 2013($0.07)($0.06)+$0.01($0.04)
5/16/2013Q1 2013($0.07)($0.04)+$0.03($0.04)
4/2/2013Q4 2012($0.05)($0.05)($0.10)
11/15/2012Q312($0.08)($0.08)  
8/15/2012Q2 2012($0.04)($0.01)+$0.03($0.01)
5/16/2012Q1 2012($0.08)($0.04)+$0.04($0.04)
4/2/2012Q4 2011($0.06)($0.09)($0.03)($0.08)
11/15/2011Q3 2011($0.07)($0.05)+$0.02($0.05)
8/16/2011Q2 2011($0.08)($0.06)+$0.02($0.06)
5/16/2011Q1 2011($0.08)($0.08)($0.08)
4/1/2011Q4 2010($0.07)($0.04)+$0.03($0.04)
11/16/2010Q3 2010($0.09)($0.05)+$0.04($0.05)
8/13/2010Q2 2010($0.07)($0.07)($0.07)
5/18/2010Q1 2010($0.06)($0.06)($0.06)
4/1/2010Q4 2009($0.06)($0.06)($0.06)
11/12/2009Q3 2009($0.11)($0.09)+$0.02($0.09)
8/7/2009Q2 2009($0.20)($0.13)+$0.07($0.13)
5/14/2009Q1 2009($0.29)($0.22)+$0.07($0.22)
3/27/2009Q4 2008($0.27)($0.27)($0.27)
11/14/2008Q3 2008($0.22)($0.22)($0.22)
8/15/2008Q2 2008($0.14)($0.19)($0.05)($0.19)
5/16/2008Q1 2008($0.12)($0.13)($0.01)($0.13)
3/26/2008Q4 2007($0.07)($0.07)($0.07)












Catalyst Pharmaceuticals Earnings - Frequently Asked Questions

When is Catalyst Pharmaceuticals's earnings date?

Catalyst Pharmaceuticals has not confirmed its next earnings publication date, but the company's estimated earnings date is Tuesday, May 9th, 2023 based off last year's report dates. Learn more on CPRX's earnings history.

How much revenue does Catalyst Pharmaceuticals generate each year?

Catalyst Pharmaceuticals (NASDAQ:CPRX) has a recorded annual revenue of $214.20 million.

How much profit does Catalyst Pharmaceuticals generate each year?

Catalyst Pharmaceuticals (NASDAQ:CPRX) has a recorded net income of $83.08 million. CPRX has generated $0.74 earnings per share over the last four quarters.

What is Catalyst Pharmaceuticals's price-to-earnings ratio?

Catalyst Pharmaceuticals (NASDAQ:CPRX) has a trailing price-to-earnings ratio of 22.59 and a forward price-to-earnings ratio of 11.86.

What is Catalyst Pharmaceuticals's EPS forecast for next year?

Catalyst Pharmaceuticals's earnings are expected to grow from $1.41 per share to $1.58 per share in the next year, which is a 12.06% increase.

More Earnings Resources from MarketBeat

Upcoming Earnings:
This page (NASDAQ:CPRX) was last updated on 3/29/2023 by MarketBeat.com Staff